These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 22038398)
1. Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Harashima N; Inao T; Imamura R; Okano S; Suda T; Harada M Cancer Immunol Immunother; 2012 May; 61(5):667-76. PubMed ID: 22038398 [TBL] [Abstract][Full Text] [Related]
2. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014 [TBL] [Abstract][Full Text] [Related]
4. [Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway]. Zhang Y; Wu ZM; Lei BH; Lu ZJ; Zhu QY; Xu FS; Zhang MS; Liu P Zhonghua Nan Ke Xue; 2017 Sep; 23(9):828-837. PubMed ID: 29726666 [TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Zhou ZW; Li XX; He ZX; Pan ST; Yang Y; Zhang X; Chow K; Yang T; Qiu JX; Zhou Q; Tan J; Wang D; Zhou SF Drug Des Devel Ther; 2015; 9():1511-54. PubMed ID: 25834399 [TBL] [Abstract][Full Text] [Related]
6. Naringenin-Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways. Lim W; Park S; Bazer FW; Song G J Cell Biochem; 2017 May; 118(5):1118-1131. PubMed ID: 27606834 [TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer. Wu Z; Zhu Q; Yin Y; Kang D; Cao R; Tian Q; Zhang Y; Lu S; Liu P Cancer Med; 2018 Apr; 7(4):1546-1559. PubMed ID: 29533017 [TBL] [Abstract][Full Text] [Related]
8. Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway. Chen E; Chen C; Niu Z; Gan L; Wang Q; Li M; Cai X; Gao R; Katakam S; Chen H; Zhang S; Zhou R; Cheng X; Qiu Y; Yu H; Zhu T; Liu J Signal Transduct Target Ther; 2020 Nov; 5(1):216. PubMed ID: 33154351 [TBL] [Abstract][Full Text] [Related]
9. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer. Inao T; Harashima N; Monma H; Okano S; Itakura M; Tanaka T; Tajima Y; Harada M Breast Cancer Res Treat; 2012 Jul; 134(1):89-100. PubMed ID: 22203435 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia. Nomura T; Yamasaki M; Hirai K; Inoue T; Sato R; Matsuura K; Moriyama M; Sato F; Mimata H Mol Cancer; 2013 Apr; 12():27. PubMed ID: 23566222 [TBL] [Abstract][Full Text] [Related]
12. Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells. Palchetti S; Starace D; De Cesaris P; Filippini A; Ziparo E; Riccioli A J Biol Chem; 2015 Feb; 290(9):5470-83. PubMed ID: 25568326 [TBL] [Abstract][Full Text] [Related]
13. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
14. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades. Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889 [TBL] [Abstract][Full Text] [Related]
15. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer. Qi W; Morales C; Cooke LS; Johnson B; Somer B; Mahadevan D Oncotarget; 2015 Dec; 6(39):41976-87. PubMed ID: 26506516 [TBL] [Abstract][Full Text] [Related]
17. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells. Hu H; Chai Y; Wang L; Zhang J; Lee HJ; Kim SH; Lü J Mol Cancer Ther; 2009 Oct; 8(10):2833-43. PubMed ID: 19825802 [TBL] [Abstract][Full Text] [Related]
18. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
19. Picropodophyllin Inhibits the Proliferation of Human Prostate Cancer DU145 and LNCaP Cells via ROS Production and PI3K/AKT Pathway Inhibition. Zhu X; Chen X; Wang G; Lei D; Chen X; Lin K; Li M; Lin H; Li D; Zheng Q Biol Pharm Bull; 2022; 45(8):1027-1035. PubMed ID: 35908886 [TBL] [Abstract][Full Text] [Related]
20. Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines. Forbes A; Anoopkumar-Dukie S; Chess-Williams R; McDermott C Prostate; 2016 Jun; 76(8):757-66. PubMed ID: 26880388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]